CEMIP and prostate cancer: The proangiogenic role of KIAA1199 in prostate cancer has been suggested to be triggered by the MCT1-mediated elevation of lactate, which is thought to increase HIF1a lactylation and stimulate hyaluronan (HA)-binding protein KIAA1199 signaling.